[Resistance to cytostatic drugs].
Elonen
E
E
HYKS:n sisätautien klinikka, hematologian toimiala PL 340 00029 HYKS. erkki.elonen@huch.fi
D018435:ATP Binding Cassette Transporter, Subfamily B / Q000378:metabolism; D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D017209:Apoptosis; D004260:DNA Repair; D004273:DNA, Neoplasm / Q000378:metabolism; D019008:Drug Resistance, Neoplasm; D005978:Glutathione / Q000378:metabolism; D006801:Humans; D008668:Metallothionein / Q000378:metabolism; D009369:Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D059004:Topoisomerase I Inhibitors; D059005:Topoisomerase II Inhibitors; D016896:Treatment Outcome
D018435:ATP Binding Cassette Transporter, Subfamily B; D000970:Antineoplastic Agents; D004273:DNA, Neoplasm; D059004:Topoisomerase I Inhibitors; D059005:Topoisomerase II Inhibitors; D008668:Metallothionein; D005978:Glutathione